DirectHaler™ Nasal takes advantage of the patient’s anatomy to improve nasal delivery effectiveness and convenience. The innovative, integrated nasal device and delivery method enables nasal delivery of very fine particles, without the risk of pulmonary deposition.

The DirectHaler™ Nasal device has successfully been used in clinical trials, and has confirmed patient acceptability.

DirectHaler™ Nasal characteristics:

• Novel nasal delivery method: No risk of pulmonary dose
  deposition or dose swallowing.
• Easy-to-use, instruct and check.
• Single-use, disposable device, for mono-dose or bi-dose delivery
• Pre-metered and pre-filled doses.
• Visual confirmation; dose “ready” – dose “taken”
• Reliable – no mechanically moving parts
• Cost-effective (manufacture, filling & assembly)
• Hygienic – single-use disposable.
• Portable - compact size
• Ideal for therapy applications “Once-daily”, “Once-a-few-times” or “Once-only”.
• Protected by issued patents world-wide
• Proven performance and acceptability

Please "click" for each section with detailed information...
DirectHaler™ Nasal is designed to solve the problems of currently marketed nasal liquid spray delivery device systems. Read more>>

The unique DirectHaler™ Nasal delivery method can become the new dominant delivery principle in nasal drug delivery. Read more>>

Documented performance and acceptability in Phase I clinical trials and in-vitro characterisation studies. Read more>>



The straightforward appearance, covers application of integrated functionality and sophisticated fluid dynamics. Read more>>

Cost-effective manufacture, filling and assembly by proven mass production technologies. Unique supply-chain flexibility. Read more>>

Unique device customization options: sensitive powders, and combination therapy. Read more>>